Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review
- PMID: 21081729
- DOI: 10.1001/jama.2010.1651
Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review
Abstract
Context: Acute otitis media (AOM) is the most common condition for which antibiotics are prescribed for US children; however, wide variation exists in diagnosis and treatment.
Objectives: To perform a systematic review on AOM diagnosis, treatment, and the association of heptavalent pneumococcal conjugate vaccine (PCV7) use with AOM microbiology.
Data sources: PubMed, Cochrane Databases, and Web of Science, searched to identify articles published from January 1999 through July 2010.
Study selection: Diagnostic studies with a criterion standard, observational studies and randomized controlled trials comparing AOM microbiology with and without PCV7, and randomized controlled trials assessing antibiotic treatment.
Data extraction: Independent article review and study quality assessment by 2 investigators with consensus resolution of discrepancies.
Results: Of 8945 citations screened, 135 were included. Meta-analysis was performed for comparisons with 3 or more trials. Few studies examined diagnosis; otoscopic findings of tympanic membrane bulging (positive likelihood ratio, 51 [95% confidence interval {CI}, 36-73]) and redness (positive likelihood ratio, 8.4 [95% CI, 7-11]) were associated with accurate diagnosis. In the few available studies, prevalence of Streptococcus pneumoniae decreased (eg, 33%-48% vs 23%-31% of AOM isolates), while that of Haemophilus influenzae increased (41%-43% vs 56%-57%) pre- vs post-PCV7. Short-term clinical success was higher for immediate use of ampicillin or amoxicillin vs placebo (73% vs 60%; pooled rate difference, 12% [95% CI, 5%-18%]; number needed to treat, 9 [95% CI, 6-20]), while increasing the rate of rash or diarrhea by 3% to 5%. Two of 4 studies showed greater clinical success for immediate vs delayed antibiotics (95% vs 80%; rate difference, 15% [95% CI, 6%-24%] and 86% vs 70%; rate difference, 16% [95% CI, 6%-26%]). Data are absent on long-term effects on antimicrobial resistance. Meta-analyses in general showed no significant differences in antibiotic comparative effectiveness.
Conclusions: Otoscopic findings are critical to accurate AOM diagnosis. AOM microbiology has changed with use of PCV7. Antibiotics are modestly more effective than no treatment but cause adverse effects in 4% to 10% of children. Most antibiotics have comparable clinical success.
Comment in
-
Antibiotics and acute otitis media in children.JAMA. 2011 Mar 9;305(10):997; author reply 997-8. doi: 10.1001/jama.2011.240. JAMA. 2011. PMID: 21386075 No abstract available.
-
Acute otitis media: antibiotics are moderately effective and mildly increase the risk of adverse effects; prevalence of different causative bacteria changed after introduction of the heptavalent pneumococcal conjugate vaccine.Evid Based Med. 2011 Dec;16(6):181-2. doi: 10.1136/ebm1407. Epub 2011 May 11. Evid Based Med. 2011. PMID: 21561925 No abstract available.
Similar articles
-
Management of Acute Otitis Media: update.Evid Rep Technol Assess (Full Rep). 2010 Nov;(198):1-426. Evid Rep Technol Assess (Full Rep). 2010. PMID: 23126594 Free PMC article. Review.
-
Pneumococcal conjugate vaccines for preventing acute otitis media in children.Cochrane Database Syst Rev. 2019 May 28;5(5):CD001480. doi: 10.1002/14651858.CD001480.pub5. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2020 Nov 24;11:CD001480. doi: 10.1002/14651858.CD001480.pub6. PMID: 31135969 Free PMC article. Updated.
-
Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.Pediatr Infect Dis J. 2004 Sep;23(9):829-33. doi: 10.1097/01.inf.0000136868.91756.80. Pediatr Infect Dis J. 2004. PMID: 15361721
-
Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.Int J Pediatr Otorhinolaryngol. 2013 Aug;77(8):1231-6. doi: 10.1016/j.ijporl.2013.04.002. Epub 2013 Jun 6. Int J Pediatr Otorhinolaryngol. 2013. PMID: 23746414
-
Pneumococcal conjugate vaccines for preventing otitis media.Cochrane Database Syst Rev. 2014 Apr 2;(4):CD001480. doi: 10.1002/14651858.CD001480.pub4. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 May 28;5:CD001480. doi: 10.1002/14651858.CD001480.pub5. PMID: 24696098 Updated. Review.
Cited by
-
Otitis media: recent advances in otitis media vaccine development and model systems.Front Microbiol. 2024 Jan 24;15:1345027. doi: 10.3389/fmicb.2024.1345027. eCollection 2024. Front Microbiol. 2024. PMID: 38328427 Free PMC article. Review.
-
Approach for delabeling beta-lactam allergy in children.Front Allergy. 2023 Nov 15;4:1298335. doi: 10.3389/falgy.2023.1298335. eCollection 2023. Front Allergy. 2023. PMID: 38033918 Free PMC article. Review.
-
Antibiotics for acute otitis media in children.Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD000219. doi: 10.1002/14651858.CD000219.pub5. Cochrane Database Syst Rev. 2023. PMID: 37965923 Review.
-
In Vivo Optical Characterization of Middle Ear Effusions and Biofilms During Otitis Media.J Assoc Res Otolaryngol. 2023 Jun;24(3):325-337. doi: 10.1007/s10162-023-00901-6. Epub 2023 May 30. J Assoc Res Otolaryngol. 2023. PMID: 37253962 Free PMC article.
-
Intrapartum Maternal Fever and Long-Term Infectious Morbidity of the Offspring.J Clin Med. 2023 May 7;12(9):3329. doi: 10.3390/jcm12093329. J Clin Med. 2023. PMID: 37176769 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
